GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Capital Expenditure

Tauns Laboratories (TSE:197A) Capital Expenditure : 円-3,961.20 Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tauns Laboratories Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Tauns Laboratories's cash flow for capital expenditures for the six months ended in Jun. 2024 was 円-3,961 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2024 was 円-3,961.20 Mil.

Tauns Laboratories Capital Expenditure Historical Data

The historical data trend for Tauns Laboratories's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tauns Laboratories Capital Expenditure Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24
Capital Expenditure
-2,300.03 -1,165.61 -3,961.20

Tauns Laboratories Semi-Annual Data
Jun22 Jun23 Jun24
Capital Expenditure -2,300.03 -1,165.61 -3,961.20

Tauns Laboratories Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2024 was 円-3,961.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tauns Laboratories Inc (TSE:197A) » Definitions » Capital Expenditure
Comparable Companies
TSE:5889 TSE:262A TSE:7749 TSE:7979 TSE:3154 TSE:7743 TSE:7775 TSE:7702 TSE:3446 TSE:3604 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM
Traded in Other Exchanges
N/A
Address
761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Website
https://www.tauns.co.jp/en
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.

Tauns Laboratories Headlines

No Headlines